Sanofi hopes to wield insulin pen in emerging markets

Sanofi India wants to take its Allstar reusable insulin pen into emerging markets in South Asia, Africa and Latin America, executives say. The company launched the pen in India this week, eyeing exports as a next step. Report

Suggested Articles

Stephen Hahn, an oncologist who served as the chief medical officer for the MD Anderson Cancer Center, has secured Senate confirmation as FDA head.

As BMS searches for bright spots in its Opdivo-chemo combo fail from June, it’s zeroing in on squamous lung cancer patients who seemed to benefit.

The FDA's ad watchdog served its most serious violation to Alkermes Wednesday—and it took the unusual step of announcing that violation to the world.